Talis Biomedical Corp Price on August 23, 2024

If you're considering investing in Talis Pink Sheet, it is important to understand the factors that can impact its price. Talis Biomedical Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.76, which indicates the firm had a -0.76% return per unit of risk over the last 3 months. Talis Biomedical Corp exposes fifteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Talis Biomedical's Variance of 110.16, coefficient of variation of (556.77), and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide.
  
Talis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.7633

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTLIS

Estimated Market Risk

 51.36
  actual daily
96
96% of assets are less volatile

Expected Return

 -39.2
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.76
  actual daily
0
Most of other assets perform better
Based on monthly moving average Talis Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talis Biomedical by adding Talis Biomedical to a well-diversified portfolio.

Related Headline

Nuwellis Headline on 23rd of August 2024

Nuwellis announces pricing of registered direct offering and private placement, raising 0.92M for working capital and corporate purposes.

Talis Biomedical Valuation on August 23, 2024

It is possible to determine the worth of Talis Biomedical on a given historical date. On August 23, 2024 Talis was worth 4.27 at the beginning of the trading date compared to the closed value of 4.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Talis Biomedical pink sheet. Still, in general, we apply an absolute valuation method to find Talis Biomedical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Talis Biomedical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Talis Biomedical's related companies.
 Open High Low Close Volume
  4.16    4.89    4.16    4.29    22,801  
08/23/2024
  4.27    4.64    4.27    4.52    23,581  
  3.71    4.19    3.42    4.04    65,708  
Backtest Talis Biomedical  |  Talis Biomedical History  |  Talis Biomedical Valuation   PreviousNext  
Open Value
4.27
4.52
Closing Value
158.34
Upside

Talis Biomedical Trading Date Momentum on August 23, 2024

On August 26 2024 Talis Biomedical Corp was traded for  4.04  at the closing time. The top price for the day was 4.19  and the lowest listed price was  3.42 . The trading volume for the day was 65.7 K. The trading history from August 26, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 10.62% . The trading price change against the current closing price is 11.50% .

Talis Biomedical Corp Fundamentals Correlations and Trends

By evaluating Talis Biomedical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Talis Biomedical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Talis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Talis Biomedical Pink Sheet history

Talis Biomedical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talis Biomedical Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talis Biomedical stock prices may prove useful in developing a viable investing in Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. Talis Biomedical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.

Talis Biomedical Pink Sheet Technical Analysis

Talis Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Talis Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Talis Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Talis Biomedical Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Talis Biomedical Corp cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Talis Biomedical November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Talis Biomedical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talis Biomedical shares will generate the highest return on investment. By undertsting and applying Talis Biomedical pink sheet market strength indicators, traders can identify Talis Biomedical Corp entry and exit signals to maximize returns

Talis Biomedical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Talis Biomedical's price direction in advance. Along with the technical and fundamental analysis of Talis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in Talis Pink Sheet

If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals